Matus R.
- Country
- Austria
- Department
- Universitätsklinik für Augenheilkunde und Optometrie
Research Overview
- Evaluation of Efficacy and Safety of Intravitreal EYE103 Versus Ranibizumab in Diabetic Macular Edema: A Randomized, Double-Masked, Multi-Center Study
- Evaluation of Ranibizumab with or without Early Targeted Peripheral Laser Photocoagulation in Macular Edema Secondary to Central Retinal Vein Occlusion
- Efficacy and Safety Evaluation of Efgartigimod PH20 SC in Adults with Thyroid Eye Disease: A Phase 3 Randomized, Double-Masked, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 68 of 184 partner sites.
Specializations
Ophthalmology
The investigator specializes in treating advanced eye conditions, with particular expertise in retinal disorders and diabetic macular edema. Their research encompasses innovative therapeutic approaches for vision preservation and enhancement.
- Retinal Disease Management
- Anti-VEGF Therapy
- Visual Acuity Assessment
A key focus includes evaluating novel treatments using standardized ETDRS methodology for accurate vision assessment.
Endocrine Ophthalmology
The investigator has developed significant expertise in the treatment of thyroid eye disease, focusing on innovative therapeutic approaches for this complex autoimmune condition.
- Orbital Disease Management
- Proptosis Treatment
- Autoimmune Eye Disorders
Their work includes evaluation of subcutaneous therapeutic interventions for thyroid-related eye complications.
Clinical Expertise
The investigator demonstrates comprehensive expertise in advanced ophthalmic therapeutics, particularly in the evaluation of novel biological treatments for various eye conditions.
- Biological Therapy Assessment
- Vision Enhancement Protocols
- Ophthalmic Drug Development
Their research encompasses both conventional and innovative treatment modalities in ophthalmology.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.